Gary Douglas Myers
St. Jude Children's Research Hospital(US)Children's Mercy Hospital(US)Baylor College of Medicine(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial(2022)326 cited
- → Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy(2021)104 cited
- → Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia(2018)91 cited
- → Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial(2019)86 cited
- → Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)(2016)80 cited
- → Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report